https://doi.org/10.1186/1478-1336-3-3
A
Akira Sugiyama
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
226
Papers
2.2K
Citations
22
h-index
49
i10-index
Akira Sugiyama is an academic researcher from Oregon State University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Mosquito-borne diseases and control & Cardiac Fibrosis and Remodeling. The author has an h-index of 22, co-authored 193 publications.
ORCID: 0000-0003-4406-9475Papers by this author
worksGene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoforms
2005 · Nuclear Receptor · 112 citations
Cross-enhancement of ANGPTL4 transcription by HIF1 alpha and PPAR beta/delta is the result of the conformational proximity of two response elements
2014 · Genome biology · 79 citations
https://doi.org/10.1186/gb-2014-15-4-r63
Humoral immunity after second dose of BNT162b2 vaccine in Japanese communities: an observational cross-sectional study, Fukushima Vaccination Community Survey
2022 · Scientific Reports · 17 citations
https://doi.org/10.1038/s41598-022-21797-x
Long-term administration of recombinant canstatin prevents adverse cardiac remodeling after myocardial infarction
2020 · Scientific Reports · 8 citations
https://doi.org/10.1038/s41598-020-69736-y
Antibody-mimetic drug conjugate with efficient internalization activity using anti-HER2 VHH and duocarmycin
2023 · Protein Expression and Purification · 5 citations
https://doi.org/10.1016/j.pep.2023.106375
Pathological complete remission of relapsed tumor by <scp>photo‐activating</scp> antibody–mimetic drug conjugate treatment
2022 · Cancer Science · 3 citations
https://doi.org/10.1111/cas.15565
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat